Last reviewed · How we verify
NCT03754231
Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital
NA trial testing Heart rate monitoring in Vital Sign in 10 participants. Completed in 1 December 2021.
1 December 2021
Quick facts
| Lead sponsor | KK Women's and Children's Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 10 |
| Start date | 30 January 2018 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 December 2021 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Heart rate monitoring
- Respiratory rate monitoring
Conditions studied
- Vital Sign — all drugs for Vital Sign →
- Heart Rate — all drugs for Heart Rate →
- Respiratory Rate — all drugs for Respiratory Rate →
Sponsor
KK Women's and Children's Hospital
Who can join
Adults 3 to 17, any sex, with Vital Sign or Heart Rate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This proposal describes the evaluation of a CE-marked, FDA cleared vital signs Surveillance Monitoring system in a paediatric outpatient population in KK Women's and Children's Hospital ("KKH"), the main tertiary women and children hospital in Singapore. User acceptance of Aingeal and the Surveillance System will be considered within the clinical settings.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03754231
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Heart rate monitoring
Trials testing the same drug.
- NCT05887193 — Effects of Contemporary Cycling Saddle Designs on Penile Transcutaneus Oxygen and Carbon Dioxide Levels in Elite Road Cy · NA · completed
- NCT04192669 — Heart Rate Variability as a Clinical Marker in a Population of Anxio-depressive Patients · completed
- NCT03134963 — Cerebral Haemodynamic Changes During Cognitive Testing: A fTCD Study · completed
Other recruiting trials for Vital Sign
Currently open trials in the same condition.
- NCT03750318 — Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital · NA · active not recruiting
Other KK Women's and Children's Hospital trials
Trials by the same sponsor.
- NCT07534670 — Early Pregnancy Lifestyle and Glucose Patterns: A Substudy of TOFFFY · NA · not yet recruiting
- NCT07466797 — The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT) · NA · recruiting
- NCT06457750 — Anthropometric Outcomes of a Mobile Health Intervention for Eating Behaviour and Lifestyle in Infancy · NA · not yet recruiting
- NCT06481644 — Asia Pediatric Intensive Care Epidemiology and Outcomes Study · recruiting
- NCT06489834 — Group Drumming for Improving the Health of Community-Dwelling Elderly · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03754231 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by KK Women's and Children's Hospital
- Last refreshed: 31 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03754231.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing